Amanote Research
Register
Sign In
Implications of Ejection Fraction Value for Trastuzumab
BMJ
doi 10.1136/bmj.333.7570.704-a
Full Text
Open PDF
Abstract
Available in
full text
Date
September 28, 2006
Authors
D Schlosshan
C Dickinson
R Sapsford
D Dodwell
T Perren
Publisher
BMJ
Related search
Relationship of Transmural Variations in Myofiber Contractility to Left Ventricular Ejection Fraction: Implications for Modeling Heart Failure Phenotype With Preserved Ejection Fraction
Frontiers in Physiology
Physiology
Predictive Value of Left Ventricular Ejection Fraction in Stem Cell Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
Prognostic Value of Echocardiography and ECG in Heart Failure With Preserved Ejection Fraction
Bratislava Medical Journal
Influence of Ejection Fraction on Cause-Specific Mortality in Heart Failure With Preserved Ejection Fraction
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
Spironolactone for Heart Failure With Preserved Ejection Fraction
New England Journal of Medicine
Medicine
Malnutrition in Acute Heart Failure With Preserved Ejection Fraction: Clinical Correlates and Prognostic Implications
ESC heart failure
Cardiovascular Medicine
Cardiology
Blood Volume Measurements in Patients With Heart Failure and a Preserved Ejection Fraction: Implications for Diagnosing Anemia
Congestive Heart Failure
Prognosis of Heart Failure With Stable Mid-Range Ejection Fraction in Comparison to Heart Failure With Stable Reduced Ejection Fraction and Heart Failure With Stable Preserved Ejection Fraction
Journal of Cardiac Failure
Cardiovascular Medicine
Cardiology
Prognostic Implications of Microvascular Complications in Patients With Diabetes and Heart Failure With Reduced Ejection Fraction
European Journal of Heart Failure
Cardiovascular Medicine
Cardiology
